1. Home
  2. BCDA vs LNKS Comparison

BCDA vs LNKS Comparison

Compare BCDA & LNKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • LNKS
  • Stock Information
  • Founded
  • BCDA N/A
  • LNKS 1995
  • Country
  • BCDA United States
  • LNKS Malaysia
  • Employees
  • BCDA N/A
  • LNKS N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • LNKS
  • Sector
  • BCDA Health Care
  • LNKS
  • Exchange
  • BCDA Nasdaq
  • LNKS NYSE
  • Market Cap
  • BCDA 9.4M
  • LNKS 9.1M
  • IPO Year
  • BCDA N/A
  • LNKS 2024
  • Fundamental
  • Price
  • BCDA $2.27
  • LNKS $0.57
  • Analyst Decision
  • BCDA Strong Buy
  • LNKS
  • Analyst Count
  • BCDA 1
  • LNKS 0
  • Target Price
  • BCDA $25.00
  • LNKS N/A
  • AVG Volume (30 Days)
  • BCDA 94.4K
  • LNKS 267.8K
  • Earning Date
  • BCDA 03-26-2025
  • LNKS 05-11-2025
  • Dividend Yield
  • BCDA N/A
  • LNKS N/A
  • EPS Growth
  • BCDA N/A
  • LNKS N/A
  • EPS
  • BCDA N/A
  • LNKS N/A
  • Revenue
  • BCDA $58,000.00
  • LNKS $4,754,489.00
  • Revenue This Year
  • BCDA N/A
  • LNKS N/A
  • Revenue Next Year
  • BCDA N/A
  • LNKS N/A
  • P/E Ratio
  • BCDA N/A
  • LNKS N/A
  • Revenue Growth
  • BCDA N/A
  • LNKS N/A
  • 52 Week Low
  • BCDA $1.63
  • LNKS N/A
  • 52 Week High
  • BCDA $6.15
  • LNKS N/A
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 42.76
  • LNKS N/A
  • Support Level
  • BCDA $2.45
  • LNKS N/A
  • Resistance Level
  • BCDA $2.95
  • LNKS N/A
  • Average True Range (ATR)
  • BCDA 0.23
  • LNKS 0.00
  • MACD
  • BCDA -0.04
  • LNKS 0.00
  • Stochastic Oscillator
  • BCDA 20.92
  • LNKS 0.00

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About LNKS LINKERS INDUSTRIES LIMITED

Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.

Share on Social Networks: